Beijer Ref AB (FRA:BRZ0)
€ 11.38 +0.19 (+1.7%) Market Cap: 5.77 Bil Enterprise Value: 6.64 Bil PE Ratio: 27.10 PB Ratio: 2.72 GF Score: 98/100

Q4 2024 Beijer Ref AB (publ) Earnings Call Transcript

Jan 31, 2025 / 09:00 AM GMT
Release Date Price: €14.14 (-0.25%)

Key Points

Positve
  • Beijer Ref AB (FRA:BRZ0) reported a strong year with an 11% overall growth and 2% organic growth, despite challenging market conditions.
  • The company achieved a 15% growth in Q4, with a solid mix of organic and acquisition-driven growth.
  • EBITDA grew by 12% in Q4, with a stable margin of 9.2%, demonstrating strong operational performance.
  • The company successfully integrated five acquisitions, enhancing its market position and growth potential.
  • Beijer Ref AB (FRA:BRZ0) increased its dividend by 8%, reflecting confidence in its financial health and future prospects.
Negative
  • The company faced negative FX impacts due to the rapid appreciation of the US dollar against the EUR, affecting margins.
  • There was a noted dilution effect from acquisitions, particularly impacting Q4 and Q1 margins.
  • Southern Europe, particularly France, showed weak market performance, affecting overall regional stability.
  • Price pressure in Eastern Europe on heat pumps is expected to continue into Q1 2025, impacting margins.
  • The seasonality of the business, especially in the HVAC segment, leads to lower activity and margins in Q4 and Q1.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BEIJb.ST - Beijer Ref AB (publ)
Q4 2024 Beijer Ref AB (publ) Earnings Call
Jan 31, 2025 / 09:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hi, everyone. Welcome Chris over here together with you. So we'll do the normal presentation. And then after open up for questions, I think with that, we'll, we'll get straight into the presentation for, for the year and Q4. So maybe just highlighting some highlights from the full year.

I think it was a good year. Probably not all the tailwinds in the market for 2024 but despite that, we grew 11% with 2% organic growth. So pretty stable year in most of our markets and a and a positive development together with our acquisitions. Also, of course, as you follow Bayer on a on a quarterly basis, it's been a good trend on the organic side. Of course, with a very good finish. 6% organic growth here in Q4 margins, stable, 11% growth
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot